Skip header and navigation

15 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Table Infectious Disease
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Infectious Disease
May 18, 2022 What is known about hybrid immunity to COVID-19? INF220501 ESR Infectious Disease
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR Table EOC
January 4, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2-01 ESR EOC
November 2, 2020 What is the risk of reinfection from COVID-19? [Update] EOC032401v3 RR EOC
September 29, 2020 What is the evidence that runny nose or sneezing are symptoms of COVID-19? EOC092401 RR EOC
September 25, 2020 What is the evidence that runny nose or sneezing are symptoms of COVID-19? EOC092401-01 ESR EOC
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 19, 2020 Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19 EPM050901 RR Table Epidemiology & Modelling
May 12, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901-01 ESR Epidemiology & Modelling
April 11, 2020 Is the IgM or IgG immune response protective? LAB040803 RR Laboratory
April 8, 2020 Is the IgM or IgG immune response protective? LAB040803-01 ESR Laboratory
March 24, 2020 What is the risk of reinfection from COVID-19? EOC032401-01 ESR EOC

15 records – page 1 of 1.